State Street adjusts Telix Pharmaceuticals holding

State Street Corporation and its subsidiaries reported a change in their substantial holding in Telix Pharmaceuticals Limited, with the latest notice dated October 8, 2025. The previous notice was given on April 2, 2025.

The aggregate voting power held by State Street Corporation and its associates increased from 6.29% (21,229,560 ordinary shares) to 7.31% (24,734,225 ordinary shares). The report details numerous transactions involving the lending and borrowing of shares, as well as collateral received and transferred.

Key changes included various collateral received and borrowing activities. For instance, on April 14, 2025, State Street Bank and Trust Company engaged in transactions including borrowing 100,000 ordinary shares and lending 4,800 ordinary shares. These adjustments reflect ongoing portfolio management and securities lending activities.